268 related articles for article (PubMed ID: 36553600)
1. Significance of Identifying Key Genes Involved in HBV-Related Hepatocellular Carcinoma for Primary Care Surveillance of Patients with Cirrhosis.
Li Y; Li J; He T; Song Y; Wu J; Wang B
Genes (Basel); 2022 Dec; 13(12):. PubMed ID: 36553600
[TBL] [Abstract][Full Text] [Related]
2. Screening Hub Genes as Prognostic Biomarkers of Hepatocellular Carcinoma by Bioinformatics Analysis.
Zhou Z; Li Y; Hao H; Wang Y; Zhou Z; Wang Z; Chu X
Cell Transplant; 2019 Dec; 28(1_suppl):76S-86S. PubMed ID: 31822116
[TBL] [Abstract][Full Text] [Related]
3. Identification of genes predicting unfavorable prognosis in hepatitis B virus-associated hepatocellular carcinoma.
Sha M; Cao J; Zong ZP; Xu N; Zhang JJ; Tong Y; Xia Q
Ann Transl Med; 2021 Jun; 9(12):975. PubMed ID: 34277775
[TBL] [Abstract][Full Text] [Related]
4. Identifying a Three-Gene Signature and Associated Drugs for Hepatitis B Virus-Related Hepatocellular Carcinoma Using Comprehensive Bioinformatics Analysis.
Tan Y; Zhang M; Chen X; Deng Y
Tohoku J Exp Med; 2022 Sep; 258(2):149-157. PubMed ID: 36002253
[TBL] [Abstract][Full Text] [Related]
5. Identification of Potential Hub Genes Related to Diagnosis and Prognosis of Hepatitis B Virus-Related Hepatocellular Carcinoma via Integrated Bioinformatics Analysis.
Tang Y; Zhang Y; Hu X
Biomed Res Int; 2020; 2020():4251761. PubMed ID: 33376723
[TBL] [Abstract][Full Text] [Related]
6. [Bioinformatics analysis of core differentially expressed genes in hepatitis B virus-related hepatocellular carcinoma].
Yu Y; Cheng J; Mei CZ; Dai YZ
Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2022 Nov; 34(5):507-513. PubMed ID: 36464255
[TBL] [Abstract][Full Text] [Related]
7. Bioinformatics analysis of key genes and pathways for hepatocellular carcinoma transformed from cirrhosis.
He B; Yin J; Gong S; Gu J; Xiao J; Shi W; Ding W; He Y
Medicine (Baltimore); 2017 Jun; 96(25):e6938. PubMed ID: 28640074
[TBL] [Abstract][Full Text] [Related]
8. Bioinformatics Analysis of Candidate Genes and Pathways Related to Hepatocellular Carcinoma in China: A Study Based on Public Databases.
Zhang P; Feng J; Wu X; Chu W; Zhang Y; Li P
Pathol Oncol Res; 2021; 27():588532. PubMed ID: 34257537
[No Abstract] [Full Text] [Related]
9. Identification of 5 Hub Genes Related to the Early Diagnosis, Tumour Stage, and Poor Outcomes of Hepatitis B Virus-Related Hepatocellular Carcinoma by Bioinformatics Analysis.
Qiang R; Zhao Z; Tang L; Wang Q; Wang Y; Huang Q
Comput Math Methods Med; 2021; 2021():9991255. PubMed ID: 34603487
[TBL] [Abstract][Full Text] [Related]
10. [CDK1, CCNB1 and NDC80 are associated with prognosis and progression of hepatitis B virus-associated hepatocellular carcinoma: a bioinformatic analysis].
Li Y; Wu D; Wei C; Yang X; Zhou S
Nan Fang Yi Ke Da Xue Xue Bao; 2021 Oct; 41(10):1509-1518. PubMed ID: 34755666
[TBL] [Abstract][Full Text] [Related]
11. Analysis of potential key genes in very early hepatocellular carcinoma.
Wu M; Liu Z; Li X; Zhang A; Lin D; Li N
World J Surg Oncol; 2019 May; 17(1):77. PubMed ID: 31043166
[TBL] [Abstract][Full Text] [Related]
12. Identification of key genes and carcinogenic pathways in hepatitis B virus-associated hepatocellular carcinoma through bioinformatics analysis.
Kim SH; Hwang S; Song GW; Jung DH; Moon DB; Yang JD; Yu HC
Ann Hepatobiliary Pancreat Surg; 2022 Feb; 26(1):58-68. PubMed ID: 34907098
[TBL] [Abstract][Full Text] [Related]
13. Identification of key genes and pathways in hepatocellular carcinoma: A preliminary bioinformatics analysis.
Wu M; Liu Z; Zhang A; Li N
Medicine (Baltimore); 2019 Feb; 98(5):e14287. PubMed ID: 30702595
[TBL] [Abstract][Full Text] [Related]
14. Identification of significant gene and pathways involved in HBV-related hepatocellular carcinoma by bioinformatics analysis.
Xie S; Jiang X; Zhang J; Xie S; Hua Y; Wang R; Yang Y
PeerJ; 2019; 7():e7408. PubMed ID: 31392101
[TBL] [Abstract][Full Text] [Related]
15. Identification and validation of three core genes in p53 signaling pathway in hepatitis B virus-related hepatocellular carcinoma.
Yu M; Xu W; Jie Y; Pang J; Huang S; Cao J; Gong J; Li X; Chong Y
World J Surg Oncol; 2021 Mar; 19(1):66. PubMed ID: 33685467
[TBL] [Abstract][Full Text] [Related]
16. Examining the key genes and pathways in hepatocellular carcinoma development from hepatitis B virus‑positive cirrhosis.
Chen QF; Xia JG; Li W; Shen LJ; Huang T; Wu P
Mol Med Rep; 2018 Dec; 18(6):4940-4950. PubMed ID: 30272310
[TBL] [Abstract][Full Text] [Related]
17. Bioinformatics analysis of key biomarkers and potential molecular mechanisms in hepatocellular carcinoma induced by hepatitis B virus.
Li Z; Xu J; Cui H; Song J; Chen J; Wei J
Medicine (Baltimore); 2020 May; 99(20):e20302. PubMed ID: 32443377
[TBL] [Abstract][Full Text] [Related]
18. Exploring new targets for the treatment of hepatitis-B virus and hepatitis-B virus-associated hepatocellular carcinoma: A new perspective in bioinformatics.
Wang Y; Wang S; Che Y; Chen D; Liu Y; Shi Y
Medicine (Baltimore); 2021 Aug; 100(33):e26917. PubMed ID: 34414947
[TBL] [Abstract][Full Text] [Related]
19. MiR-19a, miR-122 and miR-223 are differentially regulated by hepatitis B virus X protein and involve in cell proliferation in hepatoma cells.
Yu G; Chen X; Chen S; Ye W; Hou K; Liang M
J Transl Med; 2016 May; 14(1):122. PubMed ID: 27150195
[TBL] [Abstract][Full Text] [Related]
20. CDK1, CCNB1, CDC20, BUB1, MAD2L1, MCM3, BUB1B, MCM2, and RFC4 May Be Potential Therapeutic Targets for Hepatocellular Carcinoma Using Integrated Bioinformatic Analysis.
Yang WX; Pan YY; You CG
Biomed Res Int; 2019; 2019():1245072. PubMed ID: 31737652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
